Exendin-4 Agonist and Exendin(9-39)amide Antagonist of the GLP-1(7-36)amide Effects in Liver and Muscle
- 1 May 1997
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 341 (1) , 1-7
- https://doi.org/10.1006/abbi.1997.9951
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Glucagon-like peptide-1 binding to rat skeletal musclePeptides, 1995
- Glucagon-like peptide-1 binding to rat hepatic membranesJournal of Endocrinology, 1995
- Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing PolypeptideEndocrine Reviews, 1995
- Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.Endocrinology, 1994
- Potent glycogenic effect of GLP-1(7?36)amide in rat skeletal muscleDiabetologia, 1994
- Glucagon‐like peptide 1: A potent glycogenic hormoneFEBS Letters, 1994
- Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.Endocrinology, 1994
- Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.Endocrinology, 1993
- Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes MellitusNew England Journal of Medicine, 1992
- Insulin regulation of hepatic glycogen synthase and phosphorylaseBiochemistry, 1978